Even though majority of U.S.-based cannabis organizations and many foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a marijuana that is few are exchanged from the NASDAQ. Some investors choose stocks which can be noted on the NASDAQ with other exchanges for their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For instance, due to the fact cannabis industry is continuing to grow in current months and years, uplisting from an OTC market to a professional U.S. change is now an advertising achievement for a lot of increasing cannabis organizations. (For associated reading, see “Understanding Medical Cannabis vs. Recreational Cannabis shares”)
An increasing quantity of cannabis businesses are now being noted on reputable U.S. exchanges in place of being exchanged in the OTC market showing the quick growth of the cannabis industry.
NASDAQ-listed Marijuana Stocks
The NASDAQ ended up being the very first electronic trade and is certainly similar to technology and biotechnology. The cannabis businesses regarding the NASDAQ mirror this, and also the most of them operate when you look at the biotech area of this industry. Here you will find the NASDAQ-listed marijuana stocks, in alphabetical order, at the time of October 26, 2019, with a dysfunction of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech business involved in the manufacturing of medical cannabis medications. Research and development around Arena’s APD371 could be the focus that is primary of firm’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is really a blank check business that is in a merger contract with Kalyx developing Inc. Kalyx is a prominent investment rely upon the regulated cannabis industry in the usa.
- The cannabis industry, especially the part of cannabis and biotech, is attracting investor attention that is substantial.
- Cannabis is being found in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
- Organizations may also be developing cannabinoid services and products for autism range disorders, schizophrenia, glioma, Tourette syndrome, epileptic problems, Prader-Willi Syndrome (an inherited disorder), and addiction that is amphetamine.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although all the company’s clinical-stage what is cbd oil services and products target opioid receptors, Cara happens to be conducting preclinical research on cannabinoids to treat neuropathic pain.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is just a cannabis biotech business. The team’s research, development, and manufacturing are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, as well as other diseases.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is just a cannabis that are canadian. The group has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but additionally having a partner that is well-established into the advertising of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage add-ons and vaporization equipment and services and products to retail clients in the U.S. and Canada. Furthermore, it runs e-commerce internet sites for extra product product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is developing a profile of cannabinoid medications. These medications consist of Sativex to treat spasticity associated with sclerosis that is multiple cancer discomfort and Epidiolex for the treatment of youth epilepsy. Sativex is commercialized much more compared to a dozen nations outside of the united states of america and has now gotten regulatory approval in various other nations. Epidiolex received Food And Drug Administration approval being a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of severe, very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid products for autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is really a clinical-stage biopharmaceutical business that is developing medications predicated on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate for use on cannabis plants when you look at the California cultivation market.
Modern Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is really a maker of beverages based on yerba mate, green tea leaf, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted in the NASDAQ in May of 2019, which makes it probably one of the most current cannabis organizations to record from the exchange that is popular. The business happens to be rapidly expanding its manufacturing capability and could have the ability to create up to 113,000 kilograms of item per 12 months because of the end of 2019.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation runs within the enforcement sector. The company’s business operations support drug assessment through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the release of a brand new Palmetto model of recreational cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical company concentrated regarding the growth of cannabinoid-based medications. Therapix’s present pipeline includes products targeted to treat Tourette syndrome and mild intellectual disability.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the initial marijuana-related business to have a short general public offering (IPO) in the us. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.
Village Farms Global (NASDAQ:VFF)
Village Farms Global is considered the most current cannabis stock to begin dealing on the NASDAQ. The business’s stocks became readily available for trade on 21, 2019 february. The organization possesses decades-long history in greenhouse produce production and has now only recently shifted a few of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted in the development of artificial cannabinoid treatments for transdermal (through your skin) distribution. Their pipeline presently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.